Ventricular tachyarrhythmia in a 78-year-old woman with essential thrombocythaemia.

Author: GreenspanAllan, LuMarvin, Rodriguez-ZiccardiMary, RubioManolo

Paper Details 
Original Abstract of the Article :
Anagrelide is a phosphodiesterase-3 inhibitor used in the treatment of essential thrombocythaemia. Cardiovascular side effects such as ventricular tachycardia and cardiomyopathy are rare but potentially fatal and should be made known to patients before starting the medication. It usually arises with...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836625/

データ提供:米国国立医学図書館(NLM)

A Rare Case of Ventricular Tachyarrhythmia: A Cautionary Tale for Essential Thrombocythaemia Patients

Essential thrombocythaemia (ET), a rare blood disorder characterized by an abnormally high platelet count, can sometimes lead to serious complications. This study reports a case of a 78-year-old woman with ET who developed ventricular tachyarrhythmia, a potentially life-threatening heart rhythm disorder, after starting treatment with anagrelide, a medication used to manage ET. The authors emphasize the importance of being aware of the potential cardiovascular side effects of anagrelide, particularly in elderly patients, and the need for close monitoring.

A Hidden Danger in the Desert of Blood

Essential thrombocythaemia can be a difficult journey, with potential pitfalls and complications. This study reveals a rare but serious side effect of anagrelide, emphasizing the importance of being vigilant and aware of potential risks associated with medications. It's like encountering a hidden sandstorm in the desert – a sudden and unexpected threat that requires immediate attention and action.

Navigating the Risks of ET Treatment

This case highlights the importance of open communication between patients and healthcare professionals about potential risks and side effects of medications. It’s crucial to be informed about the potential complications of ET treatment and to be prepared to take appropriate action if any adverse effects occur. It’s like a skilled desert navigator, always prepared for unexpected challenges and equipped with the knowledge and resources to navigate safely.

Dr.Camel's Conclusion

This case underscores the importance of careful monitoring and awareness of potential side effects when treating patients with ET. It's a reminder that even in the familiar territory of managing a chronic condition, there can be unexpected twists and turns. Open communication and close collaboration between patients and healthcare providers are essential to ensure a safe and successful journey.

Date :
  1. Date Completed 2018-09-12
  2. Date Revised 2020-02-09
Further Info :

Pubmed ID

29437800

DOI: Digital Object Identifier

PMC5836625

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.